<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="../../external.html?link=http://www.w3.org/1999/xhtml"><head><title>Issues Berkeley Medical Journal</title>







  

  
  
  <meta http-equiv="content-language" content="English" />

  
  <meta name="description" content="ISSUES Berkeley Medical Journal--Berkeley undergraduate science, medicine, and health journalism." />

  
  <meta name="keywords" content="Issues, berkeley, university, california, journalism, science, medicine, undergraduate, journal, ISSUES Berkeley Medical Journal, Issues Berkeley" />

  
  <meta name="owner" content="ISSUES Berkeley Medical Journal" />

  
  <meta name="revisit-after" content="20 days" />

  
  <meta name="rating" content="General" />

  
  <meta name="robots" content="all" />

  
  <link rel="stylesheet" type="text/css" href="../style.css" /></head><body>
<div id="container">
<!--

******************************

	Header + Navigation

******************************

-->
<div id="header"><a href="../index.html"><img src="../images/logo.jpg" style="border: 0px solid ; float: left; width: 246px; height: 40px;" alt="" align="left" /></a></div>
<div id="nav">
<ul>
  <li><a href="contactus.html" title="Contact Us">Contact&nbsp;Us</a></li>
  <li><a href="archive.html" title="Publications">Archive</a></li>
  <li><a href="courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="aboutus.html" title="About Us">About&nbsp;Us</a></li>
  <li><a href="index.html" title="Home">Home</a></li>
</ul>
</div>
<!--

******************************

	News Updates Column

******************************

-->
<div id="newsupdate">
<h1>Links and Updates</h1>
<div class="newstitle">.site<span>Navigation*</span></div>
<div id="MainText-left">
<ul>
  <li><a href="index.html" title="Home">Home</a></li>
  <li><a href="aboutus.html" title="About Us">About Us</a></li>
  <li><a href="courseinfo.html" title="Course Info">Course Info</a></li>
  <li><a href="archive.html" title="Publications">Archive</a></li>
  <li><a href="staff.html" title="Staff">Staff</a></li>
  <li><a href="joinus.html" title="Opportunities">Join Us<br />
    </a></li>
  <li><a href="advertise.html" title="Advertisements">Advertise</a></li>
  <li><a href="contactus.html" title="Contact Us">Contact Us</a></li>
</ul>
</div>
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<div class="newstitle"><span><br />
</span></div>
<br />
<p><b><br />
<br />
</b></p>
<div class="newstitle"><span><b><br />
</b></span></div>
<b><br />
</b>
<p><b><b><br />
<br />
<br />
<a href="../../external.html?link=http://www.ocf.berkeley.edu/">
<br />
</a> </b></b></p>
</div>
<!--

******************************

   Welcome Message IMG+TEXT

******************************

-->
<div class="rightcontainer">
<div id="welcome"><b><b>science. medicine. health.</b></b></div>
<div id="content">
<p style="text-align: center;"><a href="20.2_Lee_N_Art_of_War_1.html"><small><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;">return to
previous page</span></small></a></p>
<p style="text-align: center;"><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;"><a href="20.2_Issue.html"><small>return
to issue</small></a><br />
</span></p>
<p><br />
</p>
<p style="font-style: italic;"><small>continued from Art of War</small></p>
<p><small><br />
</small></p>
<p><small> &nbsp;&nbsp; So to counter this issue, scientists Wadih Arap
and Renata Pasqualin decided to collaborate on making a synthetic
version of the AMP molecule called KLAKLAK-2, to give humans an edge
against our drug resistant adversaries.&nbsp; KLAKLAK-2 is similar to
all naturally-occurring AMP&#8217;s in that it has a left-handed twist to its
corkscrew shape.&nbsp;&nbsp; In order to make the molecule more
competitive against cancer and bacteria, the scientists altered the
molecule to give it a right-handed, counterclockwise twist
instead.&nbsp; Cancer and bacteria have evolved always fighting against
the left-handed versions of AMPs, since previously, they were the only
kind that existed. Because of this, cancer and bacteria have a
diminished ability to resist man-made &#8216;mirror&#8217; compounds because they
cannot use the machinery they have evolved to disarm the right-handed
weapons, says Ben-Jacob.&nbsp; To enhance the effectiveness of this
treatment, the Rice team has suggested combining the modified
KLAKKLAK-2 with the original toxin, which would &#8220;confuse&#8221;
drug-resistant bacteria, essentially delivering the drug version of a
One-Two Punch. &nbsp;<br />
</small></p>
<p><small><br />
</small></p>
<p><small>&nbsp;&nbsp;&nbsp; In the arms race against drug-resistant
diseases, &#8220;Nature is smarter than we are,&#8221; Ben-Jacob says. &#8220;Time and
again, we have seen that seemingly simple cellular foes like bacteria
and cancer can learn to mount effective defenses against any new drug
we create. It is time to accept them as sophisticated enemies. We
should attack them in much the same way that a well-trained boxer or
military commander would go after a wily opponent &#8212; with multiple,
coordinated blows of very different kinds.&#8221; Our survival depends upon
it. <br />
</small><br />
<br />
</p>

<p>
</p>
<h3><b><b><b><b>About the Author
</b></b></b></b></h3>
<p>
</p>
<p><small>Nicole Lee, class of 2015, is an Integrative Biology major pursuing a career as a PA.</small></p>
<p><br />
</p>
<p style="text-align: center;"><a href="20.2_Lee_N_Art_of_War_1.html"><small>return to previous
page</small></a></p>
<p style="text-align: center;"><a href="20.2_Issue.html"><small>return
to issue</small></a><br />
</p>
<p style="text-align: center;"><br />
</p>
<div style="text-align: right;"><span style="font-family: &quot;Trebuchet MS&quot;,Helvetica,sans-serif;" /></div>
</div>
</div>
<div id="footer"> Copyright © 2013 ISSUES Berkeley Medical Journal |
Designed by MockUp | <a href="mailto:bmjwebm@gmail.com">Contact
Webmaster </a><br />
Not an official University publication. Content not necessarily
reflective of UC Berkeley or the ASUC.</div>
</div>

</body></html>